A new Norwegian technology may help stop the increase of antibiotic multi-resistance.
The first-year students of the Researcher Programme met their mentors.
IMPRESS Norway, a national clinical study for cancer precision medicine, will begin in 2021.
These are some of the main points for cancer innovation in the newly released state budget.
Our member Vaccibody signs multi-million-dollar agreement.
Oslo Cancer Cluster (OCC) Innovation Park and Incubator plans to expand by 5o ooo m² in the coming years.